Navigation Links
ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
Date:1/22/2009

Represents Latest Advancement for ConvaTec Proprietary Hydrofiber(R) Technology

SKILLMAN, N.J., Jan. 22 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that the company received expanded indications from the U.S. Food and Drug Administration (FDA) for its AQUACEL(R) and AQUACEL(R) Ag Dressings with Hydrofiber(R) Technology for the management of surgical wounds that heal by primary intent, building upon the products' extensive indications for chronic and acute wounds.

AQUACEL(R) and AQUACEL(R) Ag Dressings are soft, absorbent barrier wound dressings which feature the unique gelling benefits of ConvaTec Hydrofiber(R) Technology. AQUACEL(R) Ag Dressing also provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).(1)

"Approximately 27 million surgical procedures are performed annually in the United States.(2) ConvaTec is extremely pleased that, with this expanded indication, health care professionals will now be able to safely and effectively use both AQUACEL(R) and AQUACEL(R) Ag Dressings across a broad spectrum of wounds related to surgical incisions," said Marcus Schabacker, Chief Scientific Officer.

In addition to the new indication for the management of surgical wounds that heal by primary intent (including dermatologic, orthopedic and vascular incisions), the initial indication for use in surgical wounds left to heal by secondary intent was clarified to specifically encompass dehisced surgical incisions. AQUACEL(R) Ag Dressing also received an expanded indication for the management of infected wounds.

"The expanded indication for use in orthopedic wounds is particularly significant," added Schabacker. Blistering, often associated with orthopedic dressings, can lead to infection, delay healing and increase hospital length of stay.(3) "AQUACEL(R) and AQUACEL(R) Ag Dressings provide an effective alternative for the management of orthopedic surgical wounds."

These latest indications for AQUACEL(R) and AQUACEL(R) Ag Dressings follow the expanded indication each received from the FDA in 2007 for the management of painful wounds. The unique gelling action of Hydrofiber(R) Technology has been shown to reduce wound pain while the dressing is in situ and help reduce the pain and trauma upon dressing removal.(4) Hydrofiber(R) Technology is also featured in the company's recently launched Versiva(R) XC(TM) Gelling Foam Dressings.

These dressings gel on contact with wound fluid, which is locked inside the dressing to protect the periwound skin, while maintaining a moist environment to support healing and protect newly formed tissue from damage on removal.

According to a study published last year in the Journal of the American Medical Association, the estimated number of patients in the United States developing invasive MRSA infections in 2005 was 94,360.(5) Approximately 85 percent of those infections were associated with health care delivery,(5) and approximately 14 percent of those infections occurred in persons without obvious exposures to health care settings.(5)

According to the Centers for Disease Control and Prevention, surgical site infections are the third most frequently reported hospital-acquired infections, accounting for 14 to 16 percent of all nosocomial infections among hospitalized patients.(2)

AQUACEL(R) and AQUACEL(R) Ag Dressings have been studied in numerous randomized clinical trials across a variety of chronic and acute wounds, including pressure ulcers, leg ulcers, diabetic foot ulcers, partial thickness (second degree) burns and surgical incisions.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.

References

1. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen. 2004;12(3): 288-294.

2. Surgical Site Infections. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dhqp/dpac_ssi_data.html. Accessed November 17, 2008.

3. Gupta, SK, Lee S, Moseley LG. Postoperative wound blistering: is there a link with dressing usage? J Wound Care. 2002;11(7):271-273.

4. Vanscheidt W, Lazareth I, Routkovsky-Norval C. Safety evaluation of a new ionic silver dressing in the management of chronic ulcers. WOUNDS. 2003;15(11):371-378.

5. Klevens RM, Morrison M, Nadle J. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.

AQUACEL, DuoDERM, Hydrofiber and Versiva are registered trademarks of ConvaTec Inc.

XC is a trademark of ConvaTec Inc.

AP-006616-US

    Contacts

    Punnie Donohue
    ConvaTec
    Phone: 908-904-2151
    Punnie.Donohue@convatec.com

    Courtney Judd
    Weber Shandwick
    Phone: 212-445-8365
    CJudd@WeberShandwick.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
4. Mayo Clinic Announces Sharing Mayo Clinic Blog for Patients, Employees
5. Warner Chilcott Announces 2009 Financial Guidance Conference Call
6. Mayo Clinic Announces Sharing Mayo Clinic Blog for Patients, Employees
7. China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
8. Indian Head Animal Hospital Announces Dental Discounts for Pets through March 31st
9. Soldiers' Angels Announces Special Wheelchair Covers for Veterans
10. University HealthSystem Consortium Announces Dual Award for Patient Satisfaction Measurement Services
11. IntelliDOT Announces Fast, Cost-Effective Solution to Comply with New NDC Rule for CMS Outpatient Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
Breaking Medicine Technology: